L-Tyrosyl-L-prolyl-L-phenylalanyl-L-phenylalaninamide

(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-N-[(1S)-1-carbamoyl-2-phenylethyl]-3-phenylpropanamide

141801-26-5

L-Phenylalaninamide, L-tyrosyl-L-prolyl-L-phenylalanyl-

L-Tyrosyl-L-prolyl-L-phenylalanyl-L-phenylalaninamid

L-Tyrosyl-L-prolyl-L-phenylalanyl-L-phenylalaninamide

L-Tyrosyl-L-prolyl-L-phénylalanyl-L-phénylalaninamide

MFCD01321064

(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]-N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]pyrrolidine-2-carboxamide

(S)-N-((S)-1-(((S)-1-amino-1-oxo-3-phenylpropan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-1-((S)-2-amino-3-(4-hydroxyphenyl)propanoyl)pyrrolidine-2-carboxamide

H-Tyr-Pro-Phe-Phe-NH2

L-Phenylalaninamide,L-tyrosyl-L-prolyl-L-phenylalanyl-

OPRD_HUMAN

OPRD_MOUSE

OPRD_RAT

OPRK_CAVPO

OPRK_HUMAN

OPRK_RAT

OPRM_CAVPO

OPRM_HUMAN

OPRM_RAT

Tyr-Pro-Phe-Phe-NH2

Tyr-Pro-Phe-Phe-NH{2}

Δ-type opioid receptor

κ-type opioid receptor

μ-type opioid receptor